Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions: Appropriateness of Including Bleeding as a Component of a Quadruple End Point
Top Cited Papers
- 19 February 2008
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 51 (7), 690-697
- https://doi.org/10.1016/j.jacc.2007.10.040
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trialsBMJ, 2007
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCirculation, 2006
- Correlates of Bleeding Events Among Moderate- to High-Risk Patients Undergoing Percutaneous Coronary Intervention and Treated With Eptifibatide: Observations From the PROTECT–TIMI-30 TrialJournal of the American College of Cardiology, 2006
- Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary SyndromesThe American Journal of Cardiology, 2005
- Predictors and 1-year outcome of major bleeding in patients with non–ST-elevation acute coronary syndromes: Insights from the Canadian Acute Coronary Syndrome RegistriesAmerican Heart Journal, 2005
- Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary EventsEuropean Heart Journal, 2005
- Validity of composite end points in clinical trialsBMJ, 2005
- Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of ClopidogrelCirculation, 2004
- A randomized trial comparing phosphorylcholine‐coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteriesJournal of Internal Medicine, 2004
- Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary SyndromeCirculation, 2004